Martine J. Audran-Avenel

Angers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trial.

Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trial.

Journal: The British journal of dermatology

Published: December 02, 2025

Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.

Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.

Journal: JAMA dermatology

Published: March 05, 2025

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

Journal: JAMA dermatology

Published: January 24, 2024

Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.

Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.

Journal: JAMA dermatology

Published: March 19, 2020

Photodermatitis from topical phenothiazines: A case series.

Photodermatitis from topical phenothiazines: A case series.

Journal: Contact dermatitis

Published: December 28, 2019

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Journal: The British journal of dermatology

Published: August 29, 2019

A drug not recognized as a photosensitizer?

A drug not recognized as a photosensitizer?

Journal: Contact dermatitis

Published: February 27, 2019

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Journal: The Journal of investigative dermatology

Published: May 02, 2018

Is a specific eyelid patch test series useful? Results of a French prospective study.

Is a specific eyelid patch test series useful? Results of a French prospective study.

Journal: Contact dermatitis

Published: March 14, 2018

Phototesting in France: A survey by French Society for Photodermatology

Phototesting in France: A survey by French Society for Photodermatology

Journal: Annales de dermatologie et de venereologie

Published: February 11, 2018

Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.

Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.

Journal: Annales de dermatologie et de venereologie

Published: January 25, 2018

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Journal: The Journal of investigative dermatology

Published: December 06, 2017

Showing 1-12 of 39

Last Updated: 09/26/2026